LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.

AlHossiny, Midrar / Luo, Linlin / Frazier, William R / Steiner, Noriko / Gusev, Yuriy / Kallakury, Bhaskar / Glasgow, Eric / Creswell, Karen / Madhavan, Subha / Kumar, Rakesh / Upadhyay, Geeta

Cancer research

2016  Volume 76, Issue 11, Page(s) 3376–3386

Abstract: Stem cell antigen Sca-1 is implicated in murine cancer stem cell biology and breast cancer models, but the role of its human homologs Ly6K and Ly6E in breast cancer are not established. Here we report increased expression of Ly6K/E in human breast cancer ...

Abstract Stem cell antigen Sca-1 is implicated in murine cancer stem cell biology and breast cancer models, but the role of its human homologs Ly6K and Ly6E in breast cancer are not established. Here we report increased expression of Ly6K/E in human breast cancer specimens correlates with poor overall survival, with an additional specific role for Ly6E in poor therapeutic outcomes. Increased expression of Ly6K/E also correlated with increased expression of the immune checkpoint molecules PDL1 and CTLA4, increased tumor-infiltrating T regulatory cells, and decreased natural killer (NK) cell activation. Mechanistically, Ly6K/E was required for TGFβ signaling and proliferation in breast cancer cells, where they contributed to phosphorylation of Smad1/5 and Smad2/3. Furthermore, Ly6K/E promoted cytokine-induced PDL1 expression and activation and binding of NK cells to cancer cells. Finally, we found that Ly6K/E promoted drug resistance and facilitated immune escape in this setting. Overall, our results establish a pivotal role for a Ly6K/E signaling axis involving TGFβ in breast cancer pathophysiology and drug response, and highlight this signaling axis as a compelling realm for therapeutic invention. Cancer Res; 76(11); 3376-86. ©2016 AACR.
MeSH term(s) Animals ; Antigens, Ly/genetics ; Antigens, Ly/metabolism ; Antigens, Surface/genetics ; Antigens, Surface/metabolism ; Antineoplastic Agents/pharmacology ; Apoptosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Blotting, Western ; Breast Neoplasms/drug therapy ; Breast Neoplasms/immunology ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Carcinoma, Ductal, Breast/drug therapy ; Carcinoma, Ductal, Breast/immunology ; Carcinoma, Ductal, Breast/metabolism ; Carcinoma, Ductal, Breast/pathology ; Cell Proliferation ; Disease Progression ; Drug Resistance, Neoplasm ; Female ; GPI-Linked Proteins/genetics ; GPI-Linked Proteins/metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; Immunoenzyme Techniques ; Mice ; Mice, Nude ; Neoplasm Staging ; Prognosis ; RNA, Messenger/genetics ; Real-Time Polymerase Chain Reaction ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction ; Transforming Growth Factor beta/genetics ; Transforming Growth Factor beta/metabolism ; Tumor Cells, Cultured ; Tumor Escape/immunology ; Xenograft Model Antitumor Assays
Chemical Substances Antigens, Ly ; Antigens, Surface ; Antineoplastic Agents ; Biomarkers, Tumor ; GPI-Linked Proteins ; LY6E protein, human ; LY6K protein, human ; RNA, Messenger ; Transforming Growth Factor beta
Language English
Publishing date 2016--01
Publishing country United States
Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID 1432-1
ISSN 1538-7445 ; 0008-5472
ISSN (online) 1538-7445
ISSN 0008-5472
DOI 10.1158/0008-5472.CAN-15-2654
Shelf mark
Uh III Zs.135/5: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top